Enanta Pharmaceuticals (NASDAQ:ENTA) Given New $27.00 Price Target at HC Wainwright tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Virtus ETF Advisers LLC lowered its stake in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 11.5% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 12,784 shares of the biotechnology company’s stock after selling 1,654 shares during the period. Virtus ETF Advisers LLC’s holdings in Enanta Pharmaceuticals were worth $143,000 […]
Jefferies Financial Group cut shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) from a buy rating to a hold rating in a research note released on Tuesday, MarketBeat.com reports. They currently have $18.00 price target on the biotechnology company’s stock, down from their previous price target of $49.00. ENTA has been the topic of a […]
HC Wainwright restated their buy rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a research note published on Tuesday morning, Benzinga reports. They currently have a $48.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Enanta Pharmaceuticals’ Q2 2024 earnings at ($2.61) EPS, Q3 2024 earnings at […]
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year price objective […]